iBio Analyst Price Targets

Wall Street analyst price targets and consensus rating for iBio (IBIO).

Price Target Range — 8 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$5Upside to Avg. PT+552.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 17, 2026	HC Wainwright & Co.	Ananda Ghosh	Initiate	Buy	$7
Jul 2, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Jun 8, 2026	Raymond James	Martin Auster	Initiate	Outperform	$5
Apr 9, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Mar 18, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Mar 3, 2026	Jones Trading	Catherine Novack	Initiate	Buy	$7
Feb 12, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Oct 21, 2025	Oppenheimer	Jay Olson	Initiate	Outperform	$5
Oct 17, 2025	Leerink Partners	Roanna Ruiz	Initiate	Outperform	$2
Jun 25, 2025	Chardan Capital	Keay Nakae	Maintained	Buy	$5
May 6, 2025	Chardan Capital	Keay Nakae	Maintained	Buy	$5
May 5, 2025	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Dec 17, 2024	LUCID CAPITAL MARKETS	Dev Prasad	Initiate	Buy	$6
Jul 22, 2024	Brookline Capital	Kemp Dolliver	Initiate	Buy	$4
Jun 3, 2024	Chardan Capital	Keay Nakae	Maintained	Buy	$5
May 28, 2024	Chardan Capital	Keay Nakae	Initiate	Buy	$5

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Buy ratings for MNOV ($6), IBIO ($7), ROIV ($51), and PAY ($42); FHN rated Market Perform at $25.

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on iBio (NASDAQ:IBIO) with a Buy rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
Raymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

Raymond James analyst Martin Auster initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target of $5.

Benzinga Newsdesk

PRO
Jones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

Jones Trading analyst Catherine Novack initiates coverage on iBio (NASDAQ:IBIO) with a Buy rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
Chardan Capital Maintains Buy on iBio, Maintains $5 Price Target

Chardan Capital analyst Keay Nakae maintains iBio (NASDAQ:IBIO) with a Buy and maintains $5 price target.

Benzinga Newsdesk

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

iBio Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

iBio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRO
HC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRO
Raymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

PRO
Jones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRO
Chardan Capital Maintains Buy on iBio, Maintains $5 Price Target

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

People Also Watch

People Also Watch

iBio Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

iBio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PROHC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRORaymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

PROJones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PROChardan Capital Maintains Buy on iBio, Maintains $5 Price Target

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRO
Raymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

PRO
Jones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRO
Chardan Capital Maintains Buy on iBio, Maintains $5 Price Target